CanMED: NDC

Drug Name (Brand or Generic) Separate terms with OR to return results that match either term.

Major Class

Package in use from (mm/dd/yyyy):

To:

SEER*Rx Category

Clear All

10,000 Matching Results — Export these results

Click column titles once to sort ascending, and twice to sort descending.

Show Entries

NDC-11 (Package)	NDC-9 (Product)	Generic Name	Brand Name	Strength	SEER*Rx Category	Major Class (Ascending)	Minor Class	Administration Route	Package Effective Date	Package Discontinuation Date	Status
67457-0325-12	67457-0325	Bendamustine Hydrochloride	Bendamustine Hydrochloride	25.0 mg/5mL	Chemotherapy	Alkylating Agent	Nitrogen Mustard	Intravenous	April 26, 2018	Feb. 21, 2019	In Use
67457-0326-05	67457-0326	Bendamustine Hydrochloride	Bendamustine Hydrochloride	100.0 mg/20mL	Chemotherapy	Alkylating Agent	Nitrogen Mustard	Intravenous	April 26, 2018	Feb. 21, 2019	In Use
71288-0158-96	71288-0158	Busulfan	Busulfan	6.0 mg/mL	Chemotherapy	Alkylating Agent	Alkylsulfonate	Intravenous	Oct. 23, 2020		In Use
71288-0132-90	71288-0132	Melphalan hydrochloride	Melphalan hydrochloride		Chemotherapy	Alkylating Agent	Nitrogen Mustard	Intravenous	May 28, 2021		In Use
00703-4636-01	00703-4636	Streptozocin	Zanosar	100.0 mg/mL	Chemotherapy	Alkylating Agent	Nitrosourea	Intravenous	Dec. 3, 2003		In Use
16729-0048-53	16729-0048	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0048-54	16729-0048	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0050-53	16729-0050	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0050-54	16729-0050	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0051-53	16729-0051	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0129-53	16729-0129	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0129-54	16729-0129	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0130-53	16729-0130	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
16729-0130-54	16729-0130	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017		In Use
40051-0604-11	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0604-12	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0604-13	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0604-51	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0604-52	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0604-53	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0605-11	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0605-12	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0605-13	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0605-51	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0605-52	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0605-53	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0606-11	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0606-12	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0606-13	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0606-51	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0606-52	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0606-53	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0607-11	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0607-12	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0607-13	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0607-51	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0607-52	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0607-53	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0608-11	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0608-12	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0608-13	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0608-51	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0608-52	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0608-53	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0609-11	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0609-12	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0609-13	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0609-51	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0609-52	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use
40051-0609-53	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016		In Use

Found 10,000 results in 6 milliseconds — Export these results

CanMED and the Oncology Toolbox

CanMED: NDC